Humacyte, Inc. ( HUMAW) - Key Metrics
HUMAW Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.16 | -$0.09 | -$0.09 |
| 2026Q1 | $0 | -$0.09 | -$0.13 | -$0.13 |
| 2025Q4 | $0 | -$0.16 | -$0.17 | -$0.17 |
| 2025Q3 | $0 | -$0.11 | -$0.15 | -$0.15 |
| 2025Q2 | $0 | -$0.24 | -$0.17 | -$0.17 |
HUMAW Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.22 |
| 2026Q1 | 0% | -1.70 |
| 2025Q4 | 0% | -1.60 |
| 2025Q3 | 0% | -3.95 |
| 2025Q2 | 0% | -2.18 |
HUMAW
Price: $0.01
52 week price:
Earnings Per Share: -3.16 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 31189
Market Capitalization: 10.8 million